Adial Pharmaceuticals (ADIL) Other Accumulated Expenses (2018 - 2026)
Adial Pharmaceuticals (ADIL) posted Other Accumulated Expenses of $1.46 million for Q2 2026, up 291.1% from $372,560 a year earlier and up 74.0% from the prior quarter.
Adial Pharmaceuticals (ADIL) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
At the end of FY2025, Adial Pharmaceuticals' Other Accumulated Expenses came in at $660,000, up 62.9% from FY2024.
- Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 15.4% (FY2020 to FY2025).
- In prior years, Adial Pharmaceuticals' Other Accumulated Expenses was $405,246 in FY2024 (-3.8%), $421,365 in FY2023 (-44.7%), $761,509 in FY2022 (+46.2%) and $520,795 in FY2021 (+61.5%).
- The Q2 2026 figure stands as the highest quarterly Other Accumulated Expenses in data going back to Q4 2018.
- On a year-over-year basis, Other Accumulated Expenses has increased in each of the last six quarters, with growth averaging 83.7% over the last eight quarters.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q2 2026, with growth of 291.1%; the weakest was Q1 2024, with a decline of 82.1%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $837,509 (Q1 2026), $660,000 (Q4 2025) and $513,169 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Adial Pharmaceuticals | 19.04 Mn | 19.04 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.46 Mn |
| Mar 31, 2026 | 837,509.00 |
| Dec 31, 2025 | 660,000.00 |
| Sep 30, 2025 | 513,169.00 |
| Jun 30, 2025 | 372,560.00 |
| Mar 31, 2025 | 588,442.00 |
| Dec 31, 2024 | 405,246.00 |
| Sep 30, 2024 | 413,557.00 |
| Jun 30, 2024 | 273,578.00 |
| Mar 31, 2024 | 196,118.00 |
| Dec 31, 2023 | 421,365.00 |
| Sep 30, 2023 | 354,107.00 |
| Jun 30, 2023 | 276,705.00 |
| Mar 31, 2023 | 1.09 Mn |
| Dec 31, 2022 | 761,509.00 |
| Sep 30, 2022 | 686,501.00 |
| Jun 30, 2022 | 498,628.00 |
| Mar 31, 2022 | 357,535.00 |
| Dec 31, 2021 | 520,795.00 |
| Sep 30, 2021 | 444,564.00 |
Adial Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ADIL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ADIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ADIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();